The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Axcella Health Inc COM 05454B105 20,525 6,001,362 SH   DFND 2,3 0 6,001,362 0
Axcella Health Inc COM 05454B105 9,395 2,747,052 SH   DFND 3 0 2,747,052 0
Denali Therapeutics Inc COM 24823R105 139,734 7,980,263 SH   DFND 1,3 0 7,980,263 0
Evelo Biosciences Inc COM 299734103 11,168 2,970,119 SH   DFND 2,3 0 2,970,119 0
Evelo Biosciences Inc COM 299734103 38,372 10,205,282 SH   DFND 1,3 0 10,205,282 0
Evelo Biosciences Inc COM 299734103 19,018 5,058,002 SH   DFND 3 0 5,058,002 0
Kaleido Biosciences Inc COM 483347100 60,024 9,759,979 SH   DFND 1,3 0 9,759,979 0
Kaleido Biosciences Inc COM 483347100 6,088 989,976 SH   DFND 2,3 0 989,976 0
Kaleido Biosciences Inc COM 483347100 40,656 6,610,755 SH   DFND 3 0 6,610,755 0
Moderna Inc COM 60770K107 1,523,485 50,867,600 SH   DFND 2,3 0 50,867,600 0
Moderna Inc COM 60770K107 118 3,924 SH   DFND 3 0 3,924 0
Rubius Therapeutics Inc COM 78116T103 51,526 11,578,828 SH   DFND 1,3 0 11,578,828 0
Rubius Therapeutics Inc COM 78116T103 107,485 24,153,995 SH   DFND 2,3 0 24,153,995 0
Rubius Therapeutics Inc COM 78116T103 11,408 2,563,703 SH   DFND 3 0 2,563,703 0
Seres Therapeutics Inc COM 81750R102 45,278 12,682,876 SH   DFND 2,3 0 12,682,876 0
Seres Therapeutics Inc COM 81750R102 31,733 8,888,888 SH   DFND 3 0 8,888,888 0
Syros Pharmaceuticals Inc COM 87184Q107 17,425 2,938,494 SH   DFND 2,3 0 2,938,494 0